See today's BioWorld Asia
To read the full story, subscribe or sign in.

Shionogi bags agreement for Inveniai’s AI drug discovery platform Alphameld

May 4, 2021
By Gina Lee
HONG KONG – Shionogi & Co. Ltd. has inked a multitarget drug discovery collaboration for Inveniai LLC’s artificial intelligence and machine learning platform Alphameld.
BioWorld Asia Deals and M&A Artificial intelligence Gastrointestinal